INTRODUCTION
In all organisms studied, S-adenosyl-L-methionine (AdoMet) acts as the donor of methyl groups for most transmethylation reactions. It is also involved in the biosynthesis of different metabolites such as polyamines, biotin, cysteine and glutathione [1, 2] . Besides its central role in cellular metabolism, AdoMet is the subject of an increasing interest due to its pharmacological properties and therapeutic potential in liver damage and affective disorders ( [3] [4] [5] ; reviewed in [6] ).
AdoMet is synthesized from ATP and methionine, a reaction catalysed by the enzyme AdoMet synthetase (EC 2.5.1.6) in the presence of Mg2+ and K+. This enzyme has been extensively studied in bacteria, yeast, plants and animals. The enzyme has been purified from several of these organisms [7] [8] [9] [10] [11] [12] [13] [14] and cDNAs or genomic clones have been isolated [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] . In mammals, different AdoMet synthetase isoenzymes appear to exist. In fact, distinct enzyme forms have been purified from rat liver, rat kidney, bovine brain and human lymphocytes [11] [12] [13] [14] [15] . In adult rat liver, two oligomeric forms have been identified and designated high-and low-molecular mass AdoMet synthetase (also called a and , AdoMet synthetase respectively) [14] . The highmolecular-mass form is a tetramer and the low-molecular-mass form is a dimer comprised of the same polypeptide chain [14, 27] with a molecular mass of 43.7 kDa, as determined both by SDS/PAGE [25] and from the amino acid sequence deduced from its cloned cDNA [23, 25] . Another AdoMet synthetase isoenzyme, named AdoMet synthetase y, has been characterized in the extrahepatic tissues mentioned. This form has been reported to consist of two or three distinct subunits, with molecular masses ranging between 38 kDa and 53 kDa [13, 15] .
In human liver, two oligomeric forms of AdoMet synthetase have also been identified, resembling the pattern found in the rat enzyme has been determined by primer extension and Northern analysis. Among several human tissues examined, this gene is expressed only in the liver. Similar S-adenosylmethionine synthetase mRNA levels have been detected in biopsies from normal human liver and from patients with alcoholic cirrhosis and hepatocellular carcinoma. Based on these results, a possible mechanism of regulation of human liver S-adenosylmethionine synthetase is discussed.
liver [28] . Although human-liver-specific forms are being currently studied due to the involvement of this enzyme in liver diseases [28] [29] [30] , little is known about its structure and regulation. To gain more insight into these topics, we have isolated cDNA clones coding for human liver AdoMet synthetase. During the course of this work a partial sequence of the enzyme cDNA was reported [26] . Here we describe a full-length cDNA that exhibits some major differences in both the coding and non-coding regions. In addition, the AdoMet synthetase gene and mRNA have been detected. The expression of the enzyme mRNA in normal liver and livers of subjects with alcoholic cirrhosis and hepatocellular carcinoma has been studied. Finally, similarities between rat and human liver enzymes are discussed.
EXPERIMENTAL Materials
Restriction enzymes were obtained from either Boehringer Mannheim (Mannheim, Germany) Library screening and DNA sequence analysis A human liver A gtl 1 cDNA library (Clontech) was screened as described [25] using a 2.3 kb EcoRI fragment of rat liver AdoMet synthetase cDNA clone pSSRL as a probe [25] . DNA from positive phage was isolated by the plate lysate method [31] . The DNA was digested with EcoRI endonuclease and the inserts subcloned into the EcoRI site of PUC 18. Isolated cDNAs were sequenced on both strands by the dideoxy chain termination method [32] using 22 specific oligonucleotides as internal primers. These oligonucleotides were synthesized using the phosphoramidite method with an Applied Biosystem 391 DNA synthesizer. Computer analysis of sequences was performed with Strider 1.0 software (Microsoft).
Primer extension analysis
A 17-base oligonucleotide complementary to nucleotides 94-110 of the human liver AdoMet synthetase cDNA was synthesized and 5'-end-labelled with [y-32P]ATP (> 5000 Ci/mmol) and T4 polynucleotide kinase. Then 5 pmol of the end-labelled oligonucleotide was annealed to 3 ,ug of poly(A)+ RNA from human liver by incubation at 85°C for 5 min and then at 42°C for 2 h in 0.1 M Tris/HCl buffer, pH 8.3, containing 0.14 M KCl and 1 mM EDTA. The buffer was then adjusted to 1 mM dNTPs, 15 mM dithiotreitol and 10 mM MgCl2, and 25 units of placental ribonuclease inhibitor and 50 units of AMV reverse transcriptase were added. Reverse transcription was carried out at 42°C for 90 min. After synthesis, nucleic acids were precipitated and reaction products analysed on 6 % polyacrylamide gels containing 7 M urea.
Southern blot analysis
Genomic DNA was isolated from a human liver sample by standard procedures [31] . A 10 g sample of DNA was digested with appropriate restriction endonucleases, fractionated on 1 % agarose gels and blotted to nylon membranes. Prehybridization and hybridization of the membranes were performed as described [33] . The probe used for hybridizations was a 1.4 kb fragment of the human AdoMet synthetase cDNA containing the entire coding region (Figure 1 ; SHL1 clone). This probe was labelled by nick-translation to a specific radioactivity of2 x 108 c.p.m./,ug.
RNA extraction and Northern analysis RNA from various human tissues and from liver biopsies was isolated by the guanidinium thiocyanate method [34] . Samples were denatured in formaldehyde, electrophoresed in 1 % agarose/formaldehyde gels and transferred to nylon membranes. The probe used for hybridizations was the same as for the Southern analysis.
EcoRI fragment of this clone was used to screen a A gtl 1 human liver cDNA library. Out of400000 independent recombinants we obtained six partial clones designated SHLl-6, which contained inserts ranging in size between 0.5 and 1.6 kb ( Figure 1 ). All of them were subcloned into PUC 18 and sequenced on both strands using specific internal primers. The DNA sequence determination showed that clones SHL1 and SHL3 contained the entire coding region for human liver AdoMet synthetase, whereas SHL4 extended to the 3'-untranslated region but did not contain the poly(A) tract. In an attempt to obtain a full-length cDNA, this clone was used to rescreen the library. This screening yielded three additional overlapping clones (SHL11-13). The sequence at the 3'-end of the AdoMet synthetase mRNA, however, was present in a single cDNA clone (SHL13 in Figure  1 ).
A number of artifacts were also obtained from the library. These sequences appeared fused to cDNA clones SHL 3, 6, 11 and presented a high degree of sequence similarity with rat disulphide isomerase, human 18 S ribosomal RNA and Bacillus subtilis spectinomycin resistance gene.
cDNA sequence of pSHL The resulting sequence of the AdoMet synthetase cDNA (pSHL) has an overall length of 3217 nucleotides followed by the poly(A) tail ( Figure 2 ). The coding region extends from nucleotide 1 to 1185; the 5'-and 3'-untranslated regions are 71 and 1961 nucleotides long respectively. There are major differences between our cDNA sequence (pSHL) and that reported by Horikawa's group (HLSAM) [26] . In the coding region there are eight discrepancies at the nucleotide level (asterisks in Figure 2 ). The base changes at positions 426, 816, 870, 882, 1089 and 1095 do not alter the amino acid sequence; however, the changes at positions 815 and 818 render two glycines instead of the two alanines reported in HLSAM. In addition, the two sequences differ completely upstream of nucleotide residue -18 in the 5'-untranslated region. These discrepancies are discussed below. Concerning the 3' non-coding region, pSHL contains an additional fragment of 1677 nucleotides beyond the 3'-end of HLSAM. In this extension a putative polyadenylation signal translated region (overbar in Figure 2 ). Although the role of this AATAAA (thick underline in Figure 2 ) is present 16 nucleotides sequence in AdoMet synthetase mRNA regulation is not clear, it upstream from the poly(A) tail. Also noteworthy is the presence might be of physiological significance. of the trinucleotide TGT repeated in conjunction with oligo(T) stretches (bold letters in Figure 2 ). This feature, known as a G/T Prmretnina lys cluster, seems to be implicated in the efficient formation of the 3t rmrsxsso aayterminus of many mRNAs [35, 36] was used to probe EcoRI, BamHI and XbaI restriction digests of human genomic DNA. As shown in Figure 4 , a single DNA species was detected for each restriction digest. This result suggests that the gene for the liver-specific isoenzyme is present in the human genome as a single copy.
Northern analysis RNA from various human tissues was analysed by Northern hybridization using the SHLl cDNA as a probe. A hybridization signal corresponding to an mRNA species of about 3.3 kb was detected only in liver ( Figure 5 ), indicating a liver-specific expression of the gene. A similarly sized mRNA was obtained when human liver RNA was probed with the rat liver cDNA pSSRL [25] . A hybridization band was also detected when total RNA isolated from biopsies of patients with alcoholic cirrhosis or hepatocellular carcinoma was analysed ( Figure 5 ). Thus liverspecific isoenzyme mRNA is being expressed in human hepatopathies, in contrast with the data reported in rats, where the hepatic AdoMet synthetase is replaced by the extrahepatic isoenzyme in carcinogenesis [38] . On the other hand, no significant differences in AdoMet synthetase mRNA levels were observed when samples obtained from six alcoholic cirrhotic subjects were compared with the corresponding controls.
DISCUSSION
The sequence of the human liver AdoMet synthetase mRNA has been determined from nine overlapping cDNA clones (Figure 1 (1) the same sequence has been found in four independent cDNA clones (SHL1, 2, 3 and 5 in Figure 1) ; and (2) rat liver and kidney enzymes, which display sequence similarities of 95 % and 84 % respectively with the human liver enzyme, also present two glycines at these positions. Nevertheless, the reason for these discrepancies could be due to the source of the respective cDNA libraries. Regarding the 5'-untranslated region, pSHL contains 71 nucleotide residues, whereas HLSAM has 268. In addition to their length, both sequences differ completely upstream from nucleotide -18. A search of the GenBank nucleic acids sequence database revealed that the 5'-non-coding region of pSHL is highly similar to the same region in the rat liver cDNA [25] . On the contrary, the 5' sequence of the HLSAM showed 1000%
sequence identity with a fragment of human mitochondrial DNA. Furthermore, primer extension analysis showed that the 5'-non-coding region of AdoMet synthetase mRNA is about 90 nucleotides long (Figure 3 ). Therefore it seems that the sequence of HLSAM upstream from nucleotide -18 is an artifact from the cDNA library. pSHL and HLSMA cDNAs also differ in the length of the 3'-untranslated region, the former being 1677 nucleotides longer than the latter. In this extension, the poly(A) tail has been identified, as well as other regulatory features ( Figure 2 ). Previous studies have reported evidence of a close similarity between AdoMet synthetase detected in human liver and that purified from rat liver. The human liver enzyme shows, on gel filtration chromatography, two peaks of activity that coincide with the elution positions for the rat liver high-(200 kDa) and low-(110 kDa) molecular-mass forms [28] . It has been shown that the rat liver forms correspond to two different oligomeric states of the same subunit, which possesses a molecular mass of 43697 Da and is encoded by a single mRNA species of 3.4 kb [23,25] . Here we have shown, by primer extension and Northern analysis, the existence of only one mRNA for the human liver enzyme, which encodes a protein of 43 647 Da. It can therefore be expected that the two forms of the human liver AdoMet synthetase detected by gel filtration correspond to oligomeric forms similar to those observed in rat liver.
The tissue distribution of the human liver-specific AdoMet synthetase mRNA is also similar to that found in the rat. An AdoMet synthetase cDNA isolated from rat liver hybridized to an mRNA species in liver, but not in kidney, spleen, heart, brain or testis [24, 25] . Conversely, when total RNA from these tissues was analysed using a cDNA clone specific for the rat kidney AdoMet synthetase (y form), two mRNA species were identified, but no hybridization signal was observed in the liver sample [24] . Thus the mRNAs for the liver-and kidney-type isoenzymes appear to be expressed in the rat in a tissue-specific manner, consistent with the tissue distribution of the different AdoMet synthetase isoenzymes identified. The cDNA isolated from human liver detects a specific mRNA in liver, but not in kidney, spleen, gall bladder or ganglion ( Figure 5 ), suggesting tissuespecific AdoMet synthetase mRNA expression similar to that found in rat.
Consistent with these data is the finding that the liver-specific AdoMet synthetase gene appears to be present as a single copy in the human genome (Figure 4 ). This result suggests the existence of at least two different AdoMet synthetase genes to explain the distinct isoenzymes found. In this context, two structural genes for AdoMet synthetase have also been characterized in Saccharomyces cerevisiae [17, 18] and Arabidopsis thaliana [19, 20] . Therefore, in addition to its primary structure, the genetic pattern of AdoMet synthetase is exceptionally well conserved through of human liver AdoMet synthetase mRNA in liver biopsies from subjects with alcoholic cirrhosis and hepatocellular carcinoma ( Figure 5 ). It has been reported that in adult rats treated with the hepatocarcinogen N-2 fluorenylacetamide, the liver-specific AdoMet synthetase is replaced by the extrahepatic isoenzyme according to the progress of the hepatocarcinoma [38] . Our results, however, indicate that the mRNA for the human liver enzyme is being expressed in hepatocellular carcinoma. However, it cannot be excluded that the extrahepatic form is also present, since, as mentioned above, the mRNA corresponding to this isoenzyme is not recognized by the liver-specific cDNA.
On the other hand, previous reports have shown that AdoMet synthetase activity is greatly reduced in human alcoholic cirrhosis [28, 29] . The results presented here indicate that the human cirrhotic liver presents normal levels of AdoMet synthetase mRNA compared with the controls. Thus the reduced AdoMet synthetase activity observed seems to be the consequence of a post-translational event. In this regard, it has been observed that cirrhosis induced in rats by carbon tetrachloride caused a marked reduction of AdoMet synthetase activity without producing significant changes in AdoMet synthetase mRNA levels [39] .
The mechanism of regulation ofAdoMet synthetase in different organisms is so far unknown, despite recent efforts focused on the wheat embryo, Saccharomyces cerevisiae and rat liver enzymes [9, 40, 41] . The importance of the thiol groups of the molecule in maintaining its structure and activity is well established. Thus the modification of specific cysteine residues of Escherichia coli and rat liver AdoMet synthetases leads to enzyme inactivation [42] [43] [44] . These cysteines correspond to residues 90 and 240 of the E. coli sequence and to residue 150 of the rat liver sequence. Furthermore, related to the role of the thiol groups in AdoMet synthetase activity, it has been shown that the rat liver enzyme activity is modulated by glutathione [41, 45] .
Based on these data and on the presence of some putative phosphorylation sites in the rat liver AdoMet synthetase sequence, a regulatory mechanism combining phosphorylation and oxidoreduction of thiol groups has recently been proposed for this enzyme [46] . Some structural features deduced from the human liver AdoMet synthetase amino acid sequence suggest that his enzyme may undergo a similar regulation to that proposed for the rat liver enzyme. An analysis of the deduced human AdoMet synthetase sequence indicates the existence of several putative phosphorylation sites: six for casein kinase II, five for protein kinase C, two for Ca2+/calmodulin-dependent protein kinase and one for cyclic AMP-dependent protein kinase ( Figure 6 ). Some of these sites, e.g. for protein kinase C or casein kinase II, are located on the most hydrophilic area of the molecule, as revealed by a comparison of their locations with the hydrophobicity profile of the protein ( Figure 6 ). Therefore it could be expected that human liver AdoMet synthetase is phosphorylated by some of these kinases. In fact, the rat liver enzyme, which exhibits most of the potential phosphorylation sites at the same positions as those observed in the human liver enzyme [45] , appears to be phosphorylated in vitro by protein kinase C (M. A. Pajares, C. Duran and J. M. Mato, unpublished work) .
On the other hand, the cysteine residue involved in maintaining rat liver AdoMet synthetase activity (Cys-150) is conserved in the sequence of the human liver enzyme (Cys-149; doubly underlined in Figure 2 ). Interestingly, in both the rat and human liver enzymes this cysteine is located close to the ATP binding site (Figure 2 ).
In spite of the evidence obtained so far, further work is necessary to fully determine the underlying mechanisms of the regulation of human liver AdoMet synthetase. The cDNA 485 evolution.
Intriguing questions arise from the detection of normal levels The hydrophobicity of the deduced sequence of AdoMet synthetase was analysed by the Kyte-Doolittle algorithm. The relative locations of putative phosphorylation sites are shown.
described in this paper will provide a tool for expression studies to address this question. 
